Comprehensive Assessment of Morphometric, Functional, Biomechanical and Biological Interactions Between Atherosclerotic Plaque and Platelets Within the Stenosed Coronary Artery

NCT ID: NCT06275399

Last Updated: 2024-02-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

105 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-07-21

Study Completion Date

2026-07-21

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The main objective of the present study is to verify, in vivo, whether shear forces computed solely based on coronary angiography and computational fluid dynamics (CFD) techniques are associated with the biomarkers indicating the prothrombotic tendency of circulating blood in situ - distally and proximally to the coronary stenosis. The study will prospectively assess the relationship between i) the value and distribution of shear rate and shear stress (SS) estimated using three-dimensional angiography and CFD techniques, and ii) atherosclerotic plaque characteristics as assessed by optical coherence tomography (OCT), iii) functional parameters of diseased vessels assessed by vessel fractional flow reserve (vFFR), and iv) in situ platelet activation, as expressed by platelet-derived microvesicles (pMVs) and small extracellular vesicles (sEVs), platelet aggregometry and other serum prothrombotic or inflammatory biomarkers sampled within the coronary artery.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The biomechanical forces, including shear rate and shear stress exerted by circulating blood on the coronary wall and on circulating blood elements have been reported to contribute to the processes of plaque destabilization and thrombosis. Reliable estimation of shear (shear rate and shear stress) acting in vivo within the coronary artery has now become possible using imaging data and computational fluid dynamics techniques. The changing microenvironment of the plaque has a crucial role in the biochemical processes involved in remodeling the plaque itself. In this prospective, single-center study a total of 105 patients will be enrolled presenting with chronic coronary syndrome and angiographically confirmed coronary stenosis (30% - 90%) amenable to OCT imaging (according to the operator's judgment).

The groups will be assessed at the time of angiography with:

* OCT examination for precise evaluation of plaque morphology within the coronary stenosis
* Computational fluid dynamics with vFFR and estimation of value and distribution of shear rate and shear stress
* Impedance aggregometry-based platelet reactivity
* Single-particle high-resolution flow cytometry analysis of platelet-derived microvesicles and small extracellular vesicles (sEVs) as well as additional platelet activation (P-selectin, annexin-V) and inflammatory biomarkers
* Proteomic and metabolomic characterization - in the subset of patients Biomarker assessment will be done in the blood sampled directly from coronary artery (proximal and distal segment).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Coronary Syndrome Atherosclerosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients with chronic coronary syndrome and coronary stenosis (30% - 90%) amenable to OCT imaging

Patients with chronic coronary syndrome and coronary stenosis (30% - 90%) amenable to OCT imaging. The groups will be assessed at the time of angiography with:

* OCT for evaluation of plaque morphology within the coronary stenosis
* Computational fluid dynamics with vFFR and estimation of value and distribution of shear rate and shear stress
* Impedance aggregometry based platelet reactivity
* Single-particle high-resolution flow cytometry analysis of pMVs and sEVs as well as additional platelet activation and inflammatory biomarkers
* Proteomic and metabolomic characterization - in the subset of patients

Biomarker assessment will be done in the blood sampled directly from coronary artery (proximal and distal segment) arteries. Shear rate/shear stress distribution and biomarkers profile will be compared between the stenotic vessel and the non-stenotic vessel (stenoses \<30%) in the same patient.

OCT examination

Intervention Type DIAGNOSTIC_TEST

OCT examination for precise evaluation of plaque morphology within the coronary stenosis.

Blood sampling

Intervention Type DIAGNOSTIC_TEST

Blood sampling directly from coronary artery (proximal and distal segment) arteries

Assessment of vFFR and shear stress parameters

Intervention Type DIAGNOSTIC_TEST

The procedure is based on non-invasive assessment of vFFR and shear stress parameters with dedicated software, deriving parameters directly from coronary angiography with the calculation based on the computational fluid dynamics

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

OCT examination

OCT examination for precise evaluation of plaque morphology within the coronary stenosis.

Intervention Type DIAGNOSTIC_TEST

Blood sampling

Blood sampling directly from coronary artery (proximal and distal segment) arteries

Intervention Type DIAGNOSTIC_TEST

Assessment of vFFR and shear stress parameters

The procedure is based on non-invasive assessment of vFFR and shear stress parameters with dedicated software, deriving parameters directly from coronary angiography with the calculation based on the computational fluid dynamics

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Chronic coronary syndrome
* Angiographically confirmed coronary stenosis (30% - 90%)
* Amenable to OCT imaging

Exclusion Criteria

* Cardiogenic shock
* ST-segment elevation or non-ST-segment elevation myocardial infarction
* Active bleeding
* Left main coronary artery disease
* Multivessel disease
* Lesions located at a distance ≤3 mm from the ostium of the vessel
* Thrombocytopenia
* Previous coronary artery bypass grafting
* Previous coronary intervention with stent implantation or balloon angioplasty
* Previous use of novel oral anticoagulants or vitamin K antagonists
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Science Centre, Poland

OTHER_GOV

Sponsor Role collaborator

University College, London

OTHER

Sponsor Role collaborator

Queen Mary University of London

OTHER

Sponsor Role collaborator

Medical University of Warsaw

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mariusz Tomaniak

Tomaniak Mariusz MD PhD Assoc. Prof.

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Medical University of Warsaw

Warsaw, Masovian Voivodeship, Poland

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Poland

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Mariusz Tomaniak

Role: CONTACT

+48 22 5991951

Adrian Bednarek

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Mariusz Tomaniak, MD, PhD, Assoc. Prof.

Role: primary

Adrian Bednarek

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

INTERFORCE

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.